• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

stupid

  1. Quota

    Is this quota stuff serious? What in the heck is this company doing? Do they want all their reps to quit? I have been here for many many years and this is the final straw. Do better Supernus, do better.
  2. Is Mike George still an "Associate" Director

    If so his position is highly overrated.